miR-320a suppresses colorectal cancer progression by targeting Rac1.

Hongchao Zhao,Taotao Dong,Houmin Zhou,Linlin Wang,Ao Huang,Bo Feng,Yingjun Quan,Runsen Jin,Wenpeng Zhang,Jing Sun,Daohai Zhang,Minhua Zheng

DOI: https://doi.org/10.1093/carcin/bgt378

2014-01-01

Carcinogenesis

Abstract:MicroRNAs (miRNAs) have emerged as critical epigenetic regulators involved in cancer progression. miR-320a has been identified to be a novel tumour suppressive miRNA in colorectal cancer (CRC). However, the detailed molecular mechanisms are not fully understood. Here, we reported that miR-320a inversely associated with CRC aggressiveness in both cell lines and clinical specimens. Functional studies demonstrated that miR-320a significantly decreased the capability of cell migration/invasion and induced G(0)/G(1) growth arrest in vitro and in vivo. Furthermore, Rac1 was identified as one of the direct downstream targets of miR-320a and miR-320a specifically binds to the conserved 8-mer at position 11401147 of Rac1 3-untranslated region to regulate Rac1 protein expression. Over-expression of miR-320a in SW620 cells inhibited Rac1 expression, whereas reduction of miR-320a by anti-miR-320a in SW480 cells enhanced Rac1 expression. Re-expression of Rac1 in the SW620/miR-320a cells restored the cell migration/invasion inhibited by miR-320a, whereas knockdown of Rac1 in the SW480/anti-miR-320a cells repressed these cellular functions elevated by anti-miR-320a. Conclusively, our results demonstrate that miR-320a functions as a tumour-suppressive miRNA through targeting Rac1 in CRC.We demonstrated the suppressive role of miRNA-320a in CRC and that targeting Rac1 could represent a new mechanism through which this action is displayed.